Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-16

FDA Approved: PHENYTOIN SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Phenytoin Sodium from Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHENYTOIN SODIUM (phenytoin sodium)

Snippet

SUPPL AP for PHENYTOIN SODIUM (PHENYTOIN SODIUM)